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Introduction
genotype BB is associated with the lowest BMD [1] . Generally speaking, the BBAAtt genotype has usually During recent years, powerful molecular biology techbeen related to a lower bone mass. However, there is niques such as restriction enzymes and positional clonnot general agreement and several reports have failed ing have been used to identify genetic diseases even to confirm such a relationship. A recent meta-analysis before the responsible genes were characterized.
provided evidence for an effect of the VDR polymorphHowever, clinical studies have shown that bone mineral isms on BMD, but it was quantitatively modest [2] . It density (BMD) is under genetic control, probably has also been shown that environmental factors may polygenic in origin, and several candidate genes, influence the effect of genetically determined BMD. namely oestrogen and vitamin D receptors ( VDR), as Thus, VDR genetic polymorphisms have been linked well as collagen type I a 1 among others, may mediate to differences in intestinal fractional calcium absorpimportant differences in bone mass and bone metaboltion. As such, individuals with the bbaaTT haplotype ism. Since the first description by Morrison et al. [1] , showed a higher rate of radiocalcium absorption [3] . several groups have shown that genetic polymorphisms Conversely, individuals with the BB genotype had a at the 3∞-untranslated region of the VDR gene may lower efficiency of calcium absorption after dietary account for at least some of the genetic variation in calcium restriction and had a lower BMD than those bone mass. These polymorphisms are defined by the with the bb genotype [4] . This finding would be consistpresence or absence of a restriction site for the enzymes ent with the presence of functional differences in the BsmI, ApaI and TaqI. Since that initial report, VDR intestinal VDR among different VDR genotypes. gene polymorphisms have been associated with BMD, However, the mean increase of BMD after treatment peak bone density, bone turnover and the serum levels with vitamin D was significantly higher in individuals of some biochemical bone markers, as well as the rate with the BB and Bb genotypes compared with the bb of bone loss, risk of osteoporotic fracture and the genotype [5] . A more pronounced suppression of PTH relative response to several treatments of osteoporosis concentration by calcitriol has also been described in such as vitamin D or calcium.
individuals with the bb genotype. Furthermore, VDR polymorphisms have been associated with urinary calcium excretion, but in this specific study they were not VDR polymorphisms in patients without renal related to BMD [6 ] . Consequently, VDR polymorphfailure isms seem to represent one of the genetic factors affecting BMD, but they account only partially for the According to the most widely analysed BsmI restriction overall genetic effect on bone mass and this effect is site-B absence, b presence of a cleavage site-several not observed in all the screened populations. studies have documented that in patients without chronic renal failure (CRF ), the presence of two copies of the allele b (genotype bb) is associated with a greater VDR polymorphisms in primary and secondary to the development of primary and secondary hyperpa-rathyroid disorders. Whereas the BBAAtt genotype bone loss occurring after renal transplantation, since those exhibiting the B allele had lower BMD from the has usually been related to lower BMD in non-renal populations, an increased prevalence of the poly-third month after grafting. These results are in agreement with those initially presented by Morrison et al. morphic VDR alleles b, a and T has been demonstrated in sporadic primary hyperparathyroidism (HPT ). The [1] in osteoporotic populations, as well as some preliminary data described in orthotopic hepatic transplanta-VDR haplotype baT seems to be a risk factor for parathyroid adenomas, possibly by interfering with the tion (Guardiola et al., unpublished data) . Therefore, it seems likely that the effect of the VDR genotype on inhibitory action of calcitriol [7, 8] . Thus, in patients who were homozygotous the baT alleles parathyroid BMD may become more evident under challenging conditions (such as calcium restriction or following tumours exhibited lower VDR mRNA and higher parathyroid hormone (PTH ) mRNA levels than those corticosteroid treatment). Nevertheless, in CRF patients, there are so many interrelated confounding harbouring the BB, AA or tt genotypes [7] . In contrast, the BAt haplotype has recently been shown to be variables, affecting both bone and parathyroid gland function, that the relative effect of a specific genetic under-represented in primary HPT but is related to larger parathyroid lesions, as well as a less deranged background may be easily masked by other environmental or physiopathological factors with a stronger calcium sensor protein expression and parathyroid cell function. In these patients, primary HPT may be direct influence on those tissues. As a result, it seems clear that VDR polymorphisms are not one of the associated with genetic determinants, which may act mainly by altering the regulation of cell proliferation, main determinants of BMD in patients undergoing dialysis, although it may affect bone mass in some rather than the calcium-sensing mechanism of the parathyroid cells [8] .
subgroups of patients or in certain populations. However, data correlating VDR polymorphisms with secondary HPT and renal bone disease are sparse.
Physiological consequences of VDR
Higher PTH levels in individuals with the bb genotype polymorphisms and lower PTH levels in the BB genotype have been reported in patients undergoing dialysis [9, 10] . In a large haemodialysis population, Tsukamoto et al. [9] It is worth mentioning that the previously stated restriction enzymes act in an untranslated region of found that the bb genotype correlated with higher PTH levels than did the BB genotype. This finding has been the DNA, and so none of the restrictive polymorphisms change the translated protein. Consequently, it is confirmed by others. In addition, Fernandez et al. [10] have independently described the presence of a higher difficult to establish a link between the presence of the different alleles and differences in VDR expression or frequency of the BB genotype and the B allele in their low PTH group. Both PTH and osteocalcin levels have functionality. It was previously thought that the b allele was linked to a decreased transcriptional activity also been reported to be higher in the aa and bb genotype, and preliminary data showed that the aa or VDR mRNA stability, and that such reduction of VDR expression in the parathyroids of 'bb' patients genotype may be linked to an acute higher PTH increase when serum calcium was lowered during dia-could lead to decreased vitamin D action (calcitriol resistance) and contribute to parathyroid cell proliferalysis. However, many other groups have been unable to relate the VDR genotype with the severity of tion. On the contrary, it was possible that the B allele could be associated with an increased VDR mRNA secondary HPT, VDR mRNA levels or the pattern of renal osteodystrophy. All these inconsistencies, and the expression or stability. Although the baT alleles have been shown to be linked to lower VDR and higher poor reproducibility of results among different populations (either with or without CRF ), may be caused by PTH mRNA levels in primary HPT [7] , VDR polymorphisms do not seem to affect the abundance of the sampling bias, ethnicity (the prevalence of the suspected high-risk genotypes is very low in some popula-VDR mRNA in other studies and recent data do not confirm allele-specific differences in mRNA [12, 13] . As tions and this factor would limit the statistical power of analysis), confounding environmental and dietary a consequence, the mechanistic association between VDR polymorphisms and their phenotypic coninfluences, age, obesity, physical activity, sex, menopausal status or other yet unidentified factors.
sequences is not yet clear. A recently described polymorphism at the first of the two potential translation initiation sites (ATG) in the promoter region of the
VDR polymorphisms in renal transplantation
VDR gene (defined as starting codon polymorphism by the FokI restriction enzyme) may provide more helpful information [14] . The T/C polymorphism The genetic expression of VDR alleles has also been studied in renal transplant patients to analyse whether defines two distinct VDR protein lengths with apparently distinct affinity for its ligand and therefore differthese alleles may predict post-transplant loss of bone mass [11] . In this context, the bb genotype was linked ent biological activity. However, only preliminary and inconsistent information is currently available on FokI to a better rate of bone recovery between 3 and 12 months after grafting, independent of the prevailing polymorphisms in patients with CRF. Moreover, inheritance of bone mass is probably under polygenic con-PTH levels [11] . Thus, patients with the bb genotype are, to some extent, protected against the common trol and a linkage disequilibrium effect between the 4. Krall EA, Parry P, Lichter JB, Dawson-Hughes B. Vitamin D VDR gene and any other disease-causing gene loci receptor alleles and rates of bone loss: influences of years since nearby seems likely. The fact that to date no differences menopause and calcium intake. J Bone Miner Res 1995; 10: in the quantity, properties or cellular responsiveness [978] [979] [980] [981] [982] [983] [984] to calcitriol have been found, which significantly correl-5. Graafmans WC, Lips P, Ooms ME, van-Leeuwen JP, Pols HA, Uitterlinden AG. 
